封面
市場調查報告書
商品編碼
1705716

全球多組體學市場按產品/服務、類型、平台、應用、最終用途和地區分類

Global Multiomics Market, By Product & Service, By Type, By Platform, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球多組體學市場規模估計為 24.7 億美元,預計到 2032 年將達到 67.3 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 15.4%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 24.7億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年複合年成長率: 15.40% 2032年價值預測 67.3億美元
數字。 2025年全球市場佔有率多組體學市場佔有率(按地區)
全球多組學市場-IMG1

多體學是指一種綜合體學方法,它結合了多種體學技術,包括基因組學、表觀基因、轉錄組學、蛋白質組學和代謝體學,以全面了解生物系統。透過整合多種生物數據,與單體學方法相比,多體學有助於更深入了解分子機制、途徑和網路。這使得研究人員能夠更全面地整體情況生物過程和表現型。隨著研究人員意識到綜合體學策略在研究健康和疾病方面的潛力,多體學市場正在快速成長。實驗技術、生物資訊學工具和計算能力的進步正在進一步加速多體學在生物醫學研究中的應用。

市場動態:

個人化醫療、藥物發現和市場開發中體學的應用日益廣泛,是預計在未來幾年推動體學市場成長的一些關鍵因素。精準醫療擴大使用多體學方法根據患者的分子特徵制定有效的個人化治療方案。製藥公司也利用多組體學來識別新的藥物標靶和生物標記並開發精準藥物。然而,大型複雜的多組體學資料集給資料整合和管理帶來的挑戰以及缺乏全面的分析工具是限制市場成長的一些因素。在預測期內,方便用戶使用的數據分析解決方案的開發、數據處理工作流程的標準化以及體學數據存儲庫的建立可能會為多體學市場參與者創造豐厚的機會。

本研究的主要特點

  • 本報告對全球多組體學市場進行了詳細分析,並以 2024 年為基準年,展示了預測期(2025-2032 年)的市場規模和年複合成長率(CAGR)。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
  • 該報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數,概述了全球多體學市場的主要企業。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球多組體學市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員將透過用於分析全球多體學市場的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管情景
  • 服務產品組合
  • PEST分析
  • 波特分析
  • 併購場景
  • 管道分析

第4章 全球多組體學市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球多組體學市場(按產品和服務)

  • 產品
  • 裝置
  • 耗材
  • 軟體
  • 服務

6. 2020 年至 2032 年全球多組體學市場(按類型)

  • 單細胞多組體學
  • 批量體學

7. 2020 年至 2032 年全球多元組體學市場(依平台分類)

  • 基因組學
  • 轉錄組學
  • 蛋白質體學
  • 代謝體學
  • 整合組體學平台

8. 全球多組體學市場(按應用分類),2020 年至 2032 年

  • 診斷
  • 藥物研發
  • 個人化醫療
  • 農業基因組學
  • 其他(環境監測等)

9. 全球多組體學市場(依最終用途分類),2020 年至 2032 年

  • 製藥和生物技術公司
  • 學術研究所
  • 臨床研究組織(CRO)
  • 其他(醫院、診斷中心等)

第 10 章。 2020 年至 2032 年按地區分類的全球多組體學市場

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第11章競爭格局

  • BD
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Danaher, PerkinElmer Inc.
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies, Inc.
  • BGI

第12章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6633

Global Multiomics Market is estimated to be valued at USD 2.47 Bn in 2025 and is expected to reach USD 6.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.47 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.40% 2032 Value Projection: USD 6.73 Bn
Figure. Global Multiomics Market Share (%), By Region 2025
Global Multiomics Market - IMG1

Multiomics refers to the integrated omics approach that combines diverse omic technologies such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics to obtain comprehensive insights into biological systems. By integrating multiple layers of biological data, multiomics facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as researchers realize the potential of integrated omics strategies to study health and disease. Advancements in experimental techniques, bioinformatics tools, and computing power are further accelerating the application of multiomics in biomedical research.

Market Dynamics:

The growing adoption of multiomics in personalized medicine, drug discovery, and development are some of the key factors expected to drive the growth of the multiomics market in the coming years. Multiomics approaches are increasingly being used in personalized medicine to develop effective, individualized treatments based on a patient's molecular profile. Pharmaceutical companies are also leveraging multiomics to identify novel drug targets and biomarkers and develop precision therapeutics. However, data integration and management challenges posed by large and complex multiomics datasets as well as lack of comprehensive analytical tools are some of the factors expected to restrain the market growth. Development of user-friendly data analysis solutions, standardization of data processing workflows, and establishment of omics data repositories could create lucrative opportunities for multiomics market players over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global multiomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global multiomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include BD, Thermo Fisher Scientific Inc., Illumina, Inc, Danaher, PerkinElmer Inc., Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., and BGI.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global multiomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiomics market.

Detailed Segmentation:

  • Global Multiomics Market, By Product & Service
    • Products
    • Instruments
    • Consumables
    • Software
    • Services
  • Global Multiomics Market, By Type
    • Single-cell Multiomics
    • Bulk Multiomics
  • Global Multiomics Market, By Platform
    • Genomics
    • Transcriptomics
    • Proteomics
    • Metabolomics
    • Integrated Omics Platforms
  • Global Multiomics Market, By Application
    • Diagnostics
    • Drug Discovery and Development
    • Personalized Medicine
    • AgriGenomics
    • Others (Environmental Monitoring, etc.)
  • Global Multiomics Market, By End User
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Clinical Research Organizations (CROs)
    • Others (Hospitals and Diagnostic Centers, etc.)
  • Global Multiomics Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • BD
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc
    • Danaher, PerkinElmer Inc.
    • Shimadzu Corporation
    • Bruker
    • QIAGEN
    • Agilent Technologies, Inc.
    • BGI

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Multiomics Market, By Product & Service
    • Global Multiomics Market, By Type
    • Global Multiomics Market, By Platform
    • Global Multiomics Market, By Application
    • Global Multiomics Market, By End User
    • Global Multiomics Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing usage of multiomics in personalized medicine
    • Growing investment in and funding of multiomics research
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service Offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Multiomics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Multiomics Market, By Product & Service, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Instruments
  • Consumables
  • Software
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Multiomics Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Single-cell Multiomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Bulk Multiomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Multiomics Market, By Platform, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Transcriptomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Metabolomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Integrated Omics Platforms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Multiomics Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • AgriGenomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others (Environmental Monitoring, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Multiomics Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Clinical Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others (Hospitals and Diagnostic Centers, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Multiomics Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • BD
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Illumina, Inc
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Danaher, PerkinElmer Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bruker
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BGI
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us